CA
ZURA icon

Clearstead Advisors’s Zura Bio ZURA Stock Holding History

Clearstead Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-239
Closed -$251 – 3270
2025
Q2 		$251 Buy
+239
New +$286 ﹤0.01% 2556

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Clearstead Advisors's ZURA Position: Q3 2025 in Review

Clearstead Advisors sold out of Zura Bio (ZURA) in Q3 2025, closing a stake of 239 shares — an estimated $251 sold.

Clearstead Advisors first reported a position in ZURA in Q2 2025 and held it in 1 quarter. The position peaked at $251 in Q2 2025. 69 funds tracked by Wall St. Rank hold ZURA as of Q3 2025.

  • Clearstead Advisors reported no remaining Zura Bio position as of Q3 2025 after selling out during the quarter.
  • Clearstead Advisors sold 239 Zura Bio shares in Q3 2025, an estimated $251.
  • Clearstead Advisors first reported a position in Zura Bio in Q2 2025 and held it in 1 quarter.
  • Clearstead Advisors's Zura Bio position peaked at $251 in Q2 2025.
  • 69 funds tracked by Wall St. Rank held Zura Bio as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.